Top in GI: PPIs and COVID-19, colorectal cancer screening

In a recent study, researchers observed an independent, dose-response relationship between proton pump inhibitor use and COVID-19 risk. It was the top story in gastroenterology last week.

Another top story was about a sustained reduction in mortality among individuals who complied with biennial screening for colorectal cancer.

Read these and more top stories in gastroenterology below:

Proton pump inhibitor use doubles risk for COVID-19

An independent, dose-response relationship was seen between proton pump inhibitor use and COVID-19 positivity, according to a study published in the American Journal of Gastroenterology. Read more.

Biennial screening produces sustained mortality reduction in CRC

There was a sustained reduction in mortality among individuals who complied with biennial fecal occult blood test screening for colorectal cancer, according to research published in Clinical Gastroenterology and Hepatology. Read more.

The ‘Strange Fruit’ that haunts my days and dreams as a Black physician

Global demonstrations against police brutality have been inspiring. Their occurrence during the COVID-19 pandemic only amplifies their power. Read more.

Tacrolimus, beclomethasone effective treatments for ulcerative proctitis 5-ASA refractory

New data showed similar clinical and endoscopic responses between tacrolimus and beclomethasone suppositories in patients with ulcerative proctitis refractory to 5-aminosalicylic acid, according to a study published in Clinical Gastroenterology and Hepatology. Read more.

Model predicts EoE even before histology

Using updated diagnostic guidelines, researchers developed a new model to identify patients with eosinophilic esophagitis based on clinical features and endoscopic findings, according to study results. Read more.